|
Post by prcgorman2 on Jul 20, 2023 15:33:00 GMT -5
Tomorrow is options expiration. Do you think it will close at 4.50? $4.49
|
|
|
Post by peppy on Jul 20, 2023 15:42:26 GMT -5
Tomorrow is options expiration. Do you think it will close at 4.50? No clue. $4.65 takes out last months high. $4.75 is the Sanofi low resistance. schrts.co/eGdTduIU
|
|
|
Post by runner on Jul 20, 2023 15:57:31 GMT -5
Peppy, Please excuse my ignorance but what and when was the Sanofi low resistance? I thought when we were licensed to Sanofi back in the day that it was a couple of years before the stock crashed and we had the reverse split in 2017?
|
|
|
Post by sportsrancho on Jul 20, 2023 16:52:42 GMT -5
Not sure what the low was but they were insiders selling stocks six months before Sanofi dumped is so clearly the writing was on the wall.
|
|
|
Post by mymann on Jul 20, 2023 17:27:10 GMT -5
Not sure what the low was but they were insiders selling stocks six months before Sanofi dumped is so clearly the writing was on the wall. Just like insiders selling for tax purposes recently? Is the writing on the wall again?
|
|
|
Post by peppy on Jul 20, 2023 18:13:59 GMT -5
Peppy, Please excuse my ignorance but what and when was the Sanofi low resistance?I thought when we were licensed to Sanofi back in the day that it was a couple of years before the stock crashed and we had the reverse split in 2017? $3.21 the 2016 low, bounced up to $4.75 which was the final support that broke, is now resistance. (This was all pre-reverse split) $4.75 is the amount MKD needs to break to continue up. schrts.co/ipakBqFu*the world's best meal time insulin. Superiority can be seen on Continuous glucose monitors when dosed appropriately.
|
|
|
Post by mytakeonit on Jul 20, 2023 21:32:08 GMT -5
Tonight I'll bring green paint and a roller and cover up all that writing on the wall.
But, that's mytakeonit
|
|
|
Post by prcgorman2 on Jul 20, 2023 21:40:41 GMT -5
Not sure what the low was but they were insiders selling stocks six months before Sanofi dumped is so clearly the writing was on the wall. Just like insiders selling for tax purposes recently? Is the writing on the wall again? No, and no. In the first instance the writing was in legally-required filings with the SEC and is very obviously ordinary and not at all concerning from a valuation perspective. In the instance of selling before Sanofi renegged on the remaining $750M on their contract with MannKind, the writing was the obvious but unpublished withdrawal of all practical marketing resources well in advance of the first legal opportunity to back out of the contract. The first instance is non-nefarious business-as-usual. The Sanofi instance was eerily similar to the $750M obligation they renegged on with Genzyme shareholders for which they were sued in a class-action. The difference there was MannKind did not choose the same path of redress as the Genzyme shareholders which netted those shareholders a $315M settlement. www.fiercepharma.com/pharma/sanofi-pays-315m-to-genzyme-investors-over-allegations-it-delayed-lemtrada
|
|
|
Post by cretin11 on Jul 20, 2023 22:32:04 GMT -5
Not sure what the low was but they were insiders selling stocks six months before Sanofi dumped is so clearly the writing was on the wall. Just like insiders selling for tax purposes recently? Is the writing on the wall again? Legit observation. Hopefully not, but anyone claiming to have a definitive answer to this should probably be viewed with skepticism. We are not privy to all the relevant info.
|
|
|
Post by hellodolly on Jul 21, 2023 5:58:41 GMT -5
Not sure what the low was but they were insiders selling stocks six months before Sanofi dumped is so clearly the writing was on the wall. Just like insiders selling for tax purposes recently? Is the writing on the wall again? Yes, sell, sell, sell. Run far away, it's getting very shady in here with all that insider selling. By the way, UTHR must be going down the drain, too. I counted fifty (50) Form 4 Insider sales registrations with the SEC (I stopped counting back to April 14, 2023). Clearly Tyvaso is in trouble. You need to sell ASAP guy. This isn't for you. The sky is falling.
|
|
|
Post by sportsrancho on Jul 21, 2023 6:38:06 GMT -5
Just like insiders selling for tax purposes recently? Is the writing on the wall again? Legit observation. Hopefully not, but anyone claiming to have a definitive answer to this should probably be viewed with skepticism. We are not privy to all the relevant info. I don’t have any answers in my mind, except for the fact that it could have to do with the fear that we’re going into a recession, which now seems unlikely. Maybe the first 2 quarters of next year a little light. They’re saying two small more rate hikes. All speculation. People have been taking money off the table. But the CEO of TD says there’s money flowing back in now. Hard to know. People lighten up when they’re afraid of something….
|
|
|
Post by peppy on Jul 21, 2023 7:28:36 GMT -5
Legit observation. Hopefully not, but anyone claiming to have a definitive answer to this should probably be viewed with skepticism. We are not privy to all the relevant info. I don’t have any answers in my mind, except for the fact that it could have to do with the fear that we’re going into a recession, which now seems unlikely. Maybe the first 2 quarters of next year a little light. They’re saying two small more rate hikes. All speculation. People have been taking money off the table. But the CEO of TD says there’s money flowing back in now. Hard to know. People lighten up when they’re afraid of something…. If only you two/three had been there to see the insider trading and were able to warn people about Enron. c'est la vie
|
|
|
Post by agedhippie on Jul 21, 2023 9:53:37 GMT -5
Just like insiders selling for tax purposes recently? Is the writing on the wall again? Legit observation. Hopefully not, but anyone claiming to have a definitive answer to this should probably be viewed with skepticism. We are not privy to all the relevant info. In fairness you can be reasonably sure what is happening here. Senior management is paid partly in stock and partly in cash. When RSUs vest the IRS view this as salary and broker handling the issuing will ask how you want to pay the tax. Your options are; pay cash and get all the stock, or sell the equivalent of the tax bill and keep the rest. People almost invariably take the second option since the first option doesn't make sense unless the float is highly restricted which is not the case for the virtually all listed companies. (There is a weird corner case where you can prepay the IRS for the entire grant up front and then receive the RSUs without further tax, but there are some nasty gotchas with that one so it's very rare to use it)
|
|
|
Post by sayhey24 on Jul 21, 2023 11:00:26 GMT -5
Legit observation. Hopefully not, but anyone claiming to have a definitive answer to this should probably be viewed with skepticism. We are not privy to all the relevant info. In fairness you can be reasonably sure what is happening here. Senior management is paid partly in stock and partly in cash. When RSUs vest the IRS view this as salary and broker handling the issuing will ask how you want to pay the tax. Your options are; pay cash and get all the stock, or sell the equivalent of the tax bill and keep the rest. People almost invariably take the second option since the first option doesn't make sense unless the float is highly restricted which is not the case for the virtually all listed companies. (There is a weird corner case where you can prepay the IRS for the entire grant up front and then receive the RSUs without further tax, but there are some nasty gotchas with that one so it's very rare to use it) So, you think Mike sold all that stock to pay his tax bill? I though maybe he bought an oceanfront beach house and put the rest in Vanguard's S&P 500 fund.
|
|
|
Post by peppy on Jul 21, 2023 11:20:49 GMT -5
In fairness you can be reasonably sure what is happening here. Senior management is paid partly in stock and partly in cash. When RSUs vest the IRS view this as salary and broker handling the issuing will ask how you want to pay the tax. Your options are; pay cash and get all the stock, or sell the equivalent of the tax bill and keep the rest. People almost invariably take the second option since the first option doesn't make sense unless the float is highly restricted which is not the case for the virtually all listed companies. (There is a weird corner case where you can prepay the IRS for the entire grant up front and then receive the RSUs without further tax, but there are some nasty gotchas with that one so it's very rare to use it) So, you think Mike sold all that stock to pay his tax bill? I though maybe he bought an oceanfront beach house and put the rest in Vanguard's S&P 500 fund. It seems to be part of Mike's pay plan. If I couldn't see with my own eyes, that afrezza is superior blood glucose control..... however we can see. No longer is the type 1 diabetic working blind. Afrezza peak action in 35 mins, gone in 90 mins for a 4 unit dose. However the gate keepers do not want to let their subq users go. They like the rebates.... for their coffers. "Passed by Congress on January 31, 1865, and ratified on December 6, 1865, the 13th Amendment abolished slavery in the United States."
|
|